Navigation Links
Breast cancer gene could play critical role in obesity and diabetes
Date:3/12/2014

College Park, Md. -- The gene known to be associated with breast cancer susceptibility, BRCA 1, plays a critical role in the normal metabolic function of skeletal muscle, according to a new study led by University of Maryland School of Public Health researchers. Dr. Espen Spangenburg, associate professor of kinesiology, and his laboratory team are the first to identify that the BRCA1 protein is expressed in the skeletal muscle of both mice and humans, and that it plays a key role in fat storage, insulin response and mitochondrial function in skeletal muscle cells. The research is published in the Journal of Lipid Research. http://www.jlr.org/content/early/2014/02/24/jlr.M043851.abstract

"Our findings suggest that certain mutations in the BRCA1 gene may put people at increased risk for metabolic diseases like obesity and type 2 diabetes," said Dr. Spangenburg. "Without BRCA1, muscle cells store excess fat and start to look diabetic. We believe that the significance of the BRCA1 gene goes well beyond breast cancer risk."

Dr. Spangenburg and colleagues, including researchers from the University of Maryland School of Medicine, Brigham Young University, Karolinska Institutet in Sweden, and East Carolina University, found that the BRCA1 protein exists in both mouse and in human skeletal muscle. This is the first evidence since the discovery of BRCA1 in 1994 that the gene is expressed in human muscle cells.

They further established that the protein produced by the BRCA 1 gene binds with a protein known to play an important role in the metabolism of fat in muscle cells known as Acetyl-CoA carboxylase or ACC. After a period of exercise, the BRCA 1 protein binds to ACC, which helps "turns it off." This deactivation of ACC encourages the utilization of fatty acids by the muscle.

Once they established that the two proteins complex together, they sought to answer if BRCA1 plays a critical role in regulating muscle metabolic function. To do so, they "knocked out" the gene so that it was no longer being expressed in the muscle cells cultured from healthy, active and lean female subjects. This was done using shRNA technology specific for BRCA1 in human myotubes (skeletal muscle fiber cells).

The result was that the muscle cells started to look diseased. The removal of BRCA1 from the cells, which simulated what could happen in the cells of a person with a BRCA1 mutation, resulted in increased lipid storage, decreased insulin signaling, reduced mitochondrial function and increased oxidative stress. These are all key risk factors for the development of metabolic diseases, such as obesity, type 2 diabetes and cardiovascular disease.

"Our findings make it clear that BRCA1 plays a protective role against the development of metabolic disease," Dr. Spangenburg explains. "This gene needs to be there, and should be considered a target to consider in the treatment of type 2 diabetes and/or obesity."


'/>"/>

Contact: Kelly Blake
kellyb@umd.edu
301-405-9418
University of Maryland
Source:Eurekalert  

Related biology news :

1. Vitamin D increases breast cancer patient survival
2. UT Arlington study links BPA and breast cancer tumor growth
3. Second-most common breast cancer subtype may benefit from personalized treatment approach
4. Breast-feeding benefits appear to be overstated, according to study of siblings
5. New finding points to potential options for attacking stem cells in triple-negative breast cancer
6. In-hospital formula use deters breastfeeding
7. Breast cancer drug fights fungal disease
8. TGen study uncovers possible genetic markers in breast cancer that spreads to the brain
9. Researchers build 3-D structures to test breast cancer treatments
10. Engineered virus is effective against triple negative breast cancer cells
11. Long-lived breast stem cells could retain cancer legacy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast cancer gene could play critical role in obesity and diabetes
(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
(Date:5/16/2017)... 2017   Bridge Patient Portal , an ... MD EMR Systems , an electronic medical record ... have established a partnership to build an interface ... GE Centricity™ products, including Centricity Practice Solution (CPS), ... These new integrations will allow healthcare delivery networks ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
Breaking Biology News(10 mins):
(Date:9/14/2017)... ... September 14, 2017 , ... AIM Global, the worldwide standards ... Inc. has won the 2017 Case Study Competition for AIDC. The award is ... that decrease risk” and push the adoption of automated data collection systems further. ...
(Date:9/12/2017)... ... September 12, 2017 , ... ... scalable cloud-based platform for ambulatory patient monitoring and clinical trial support, earned DPharm ... Trials conference in Boston. , Launched in 2005, PhysIQ leverages artificial intelligence ...
(Date:9/12/2017)... ... September 12, 2017 , ... Soybean researchers ... to submit a "pre-proposal” by October 15, prior to completing a full grant ... are aligned with our priorities, and to encourage researchers to further develop ones ...
(Date:9/12/2017)... & Cambridge (PRWEB) , ... September 11, 2017 ... ... with US offices in Cambridge, MA, announce today that Holotype HLA and other ... at the annual meeting of the American Society for Histocompatibility and Immunogenetics ...
Breaking Biology Technology: